Precision Therapeutics (NASDAQ:AIPT) announced that its chief executive officer and director, Carl Schwartz, has made an additional investment of $1,000,000 in the Company, effective January 8, 2019. As quoted in the press release: “I have long been a firm believer in the vast potential of Precision Therapeutics and my most fervent demonstration of this belief … Continued
The post Precision Therapeutics Receives $1,370,000 Investment from CEO and Director, Carl Schwartz appeared first on Investing News Network.